Table 4. The results of the FPRP tests in each gene models.
| Gene models | OR (95% CI) | Power | Prior Probability = 0.001 |
|---|---|---|---|
| AA + AG vs. GG | OR = 1.50 | FPRP | |
| Total | 1.33 (1.17–1.51) | 0.968 | 0.011 |
| Asians | 1.63 (1.34–1.98) | 0.201 | 0.004 |
| Breast cancer | 1.26 (1.11–1.44) | 0.995 | 0.41 |
| Urologic cancer | 1.56 (1.32–1.85) | 0.326 | 0.001 |
| Lung cancer | 1.80 (1.36–2.39) | 0.104 | 0.318 |
| AA vs. AG + GG | |||
| Total | 1.28 (1.11–1.47) | 0.988 | 0.323 |
| Asian | 1.42 (1.05–1.93) | 0.637 | 0.975 |
| Lung cancer | 2.24 (1.41–3.57) | 0.046 | 0.938 |
| AA vs. GG | |||
| Total | 1.43 (1.24–1.65) | 0.744 | 0.001 |
| Asians | 1.71 (1.28–2.30) | 0.193 | 0.668 |
| Breast cancer | 1.36 (1.03–1.79) | 0.758 | 0.974 |
| Lung cancer | 2.86 (1.75–4.69) | 0.005 | 0.856 |
| AG vs. GG | |||
| Total | 1.35 (1.19–1.54) | 0.942 | 0.008 |
| Caucasians | 1.10 (1.00–1.21) | 1 | 0.980 |
| Asians | 1.58 (1.28–1.95) | 0.314 | 0.061 |
| Breast cancer | 1.26 (1.10–1.44) | 0.995 | 0.410 |
| Urologic cancer | 1.46 (1.10–1.93) | 0.575 | 0.932 |
| Hematologic malignancy | 1.29 (1.04–1.59) | 0.921 | 0.949 |
| Lung cancer | 1.62 (1.20–2.18) | 0.306 | 0.826 |
| A vs. G | |||
| Total | 1.26 (1.14–1.40) | 0.999 | 0.017 |
| Asians | 1.45 (1.25–1.68) | 0.674 | 0.001 |
| Breast cancer | 1.20 (1.08–1.33) | 1 | 0.339 |
| Urologic cancer | 1.31 (1.09–1.57) | 0.929 | 0.788 |
| Lung cancer | 1.65 (1.34–2.04) | 0.189 | 0.019 |
OR = odds ratio; FPRP = false positive report probability.